A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Encision Inc. (“Encision”, “we”, “us”, “our” or the “Company"), a medical device company based in Boulder, Colorado, has developed and markets innovative technology that provides unprecedented outcomes and patient safety in minimally invasive surgery. We believe that our patented Active Electrode Monitoring (AEM®) Surgical Instruments are changing the marketplace for electrosurgical devices and laparoscopic instruments by providing a solution to a well-documented hazard unique to laparoscopic surgery. We address market opportunities created by the increase in minimally invasive surgery (“MIS”) and surgeons’ use of electrosurgery devices in these procedures. The product opportunity exists in that monopolar electrosurgery instruments used in laparoscopic procedures provide excellent clinical results but are also susceptible to causing inadvertent collateral tissue damage outside the surgeon’s field of view.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 6.3M | 6.6M | 6.6M | 7.3M | 7.7M | 7.5M |
| Net Income | -381K | -220K | -692K | -324K | -66K | 585K |
| EPS | $-0.03 | $-0.02 | $-0.06 | $-0.03 | $-0.01 | $0.05 |
| Free Cash Flow | -545K | -109K | 132K | -1.0M | -462K | 190K |
| ROIC | -12.9% | -5.5% | -16.8% | -7.5% | -21.1% | -2.9% |
| Gross Margin | 52.6% | 53.6% | 47.6% | 54.9% | 49.4% | 51.8% |
| Debt/Equity | 0.12 | 0.80 | 0.69 | 0.43 | 0.50 | 0.80 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -320K | -172K | -641K | -303K | -595K | -62K |
| Operating Margin | -5.1% | -2.6% | -9.7% | -4.1% | -7.8% | -0.8% |
| ROE | -20.4% | -12.7% | -37.9% | -13.0% | -2.4% | 20.9% |
| Shares Outstanding | 17M | 11M | 12M | 11M | 12M | 12M |
ENCISION INC passes 2 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 51.5%. At current prices, the estimated annualized return to fair value is +8.0%.
ENCISION INC (ECIA) has a 5-year average return on invested capital (ROIC) of -10.8%. This is below average and may indicate limited pricing power.
ENCISION INC (ECIA) has a market capitalization of $2M. It is classified as a small-cap stock.
ENCISION INC (ECIA) does not currently pay a regular dividend.
ENCISION INC (ECIA) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
ENCISION INC (ECIA) reported annual revenue of $7 million in its most recent fiscal year, based on SEC EDGAR filings.
ENCISION INC (ECIA) has a net profit margin of -3.4%. The company is currently unprofitable.
ENCISION INC (ECIA) generated $-109 thousand in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
ENCISION INC (ECIA) has a debt-to-equity ratio of 0.80. This indicates moderate leverage.
ENCISION INC (ECIA) reported earnings per share (EPS) of $-0.02 in its most recent fiscal year.
ENCISION INC (ECIA) has a return on equity (ROE) of -12.7%. A negative ROE may indicate losses or negative equity.
ENCISION INC (ECIA) has a 5-year average gross margin of 51.5%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 15 years of financial data for ENCISION INC (ECIA), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
ENCISION INC (ECIA) has a book value per share of $0.15, based on its most recent annual SEC filing.
No recent press releases.